532 related articles for article (PubMed ID: 19242355)
21. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
22. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
Lai WT; Lee KT; Chu CS; Voon WC; Yen HW; Tsai LY; Sheu SH
Int J Cardiol; 2005 Feb; 98(3):459-64. PubMed ID: 15708180
[TBL] [Abstract][Full Text] [Related]
23. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
Ushiroyama T; Nosaka S; Ueki M
Int J Cardiol; 2006 Oct; 113(1):66-75. PubMed ID: 16356567
[TBL] [Abstract][Full Text] [Related]
24. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
[TBL] [Abstract][Full Text] [Related]
25. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
[TBL] [Abstract][Full Text] [Related]
26. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
27. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
Wlodarczyk J; Sullivan D; Smith M
Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
[TBL] [Abstract][Full Text] [Related]
28. Aortic plaque imaging and monitoring atherosclerotic plaque interventions.
Momiyama Y; Fayad ZA
Top Magn Reson Imaging; 2007 Oct; 18(5):349-55. PubMed ID: 18025989
[TBL] [Abstract][Full Text] [Related]
29. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography.
Taniguchi H; Momiyama Y; Fayad ZA; Ohmori R; Ashida K; Kihara T; Hara A; Arakawa K; Kameyama A; Noya K; Nagata M; Nakamura H; Ohsuzu F
Am Heart J; 2004 Jul; 148(1):137-43. PubMed ID: 15215803
[TBL] [Abstract][Full Text] [Related]
30. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.
Blanco-Colio LM; Martín-Ventura JL; Gómez-Guerrero C; Masramon X; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Egido J
Eur J Pharmacol; 2008 May; 586(1-3):259-65. PubMed ID: 18374327
[TBL] [Abstract][Full Text] [Related]
31. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.
Stulc T; Malbohan I; Malík J; Fialová L; Soukupová J; Ceska R
Am Heart J; 2003 Dec; 146(6):E21. PubMed ID: 14661010
[TBL] [Abstract][Full Text] [Related]
33. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
[TBL] [Abstract][Full Text] [Related]
34. L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits.
Rasmusen C; Moinard C; Martin C; Tricottet V; Cynober L; Couderc R
Br J Nutr; 2007 Jun; 97(6):1083-9. PubMed ID: 17391569
[TBL] [Abstract][Full Text] [Related]
35. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis.
Ashida K; Momiyama Y; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Ohmori R; Kihara T; Kameyama A; Nagata M; Nakamura H; Ohsuzu F
J Cardiovasc Magn Reson; 2007; 9(6):855-61. PubMed ID: 18066744
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
Wenger NK; Lewis SJ; Welty FK; Herrington DM; Bittner V;
Heart; 2008 Apr; 94(4):434-9. PubMed ID: 18070940
[TBL] [Abstract][Full Text] [Related]
38. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
39. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
